Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | BioPharma Credit PLC (Ordinary Share) | +20.57% |
NAV | BioPharma Credit PLC (Ordinary Share) | +21.43% |
Morningstar's Benchmark | No benchmark | -- |
Events & Activity
- BPCR:LSE price falls below 200-day moving average to 0.878 at 05:13 GMT
- BPCR:LSE price rises above 200-day moving average to 0.882 at 03:21 GMT
- BPCR:LSE price moved over +1.39% to 0.876
- BPCR:LSE price rises above 50-day moving average to 0.88 at 03:21 GMT
- BPCR:LSE price rises above 50-day moving average to 0.88 at 09:45 GMT
- BPCR:LSE trading volume exceeds daily average by +30.54%
- BPCR:LSE price falls below 15-day moving average to 0.856 at 03:00 GMT
- BPCR:LSE price rises above 15-day moving average to 0.8638 at 03:00 GMT
Key statistics
As of last trade BioPharma Credit PLC (BPCR:LSE) traded at 0.892, -5.51% below its 52-week high of 0.944, set on Jan 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 1.19bn |
---|---|
Market cap | 1.04bn USD |
Total assets | 1.17bn USD |
Total expense ratio | 1.15% |
High | 0.892 |
Low | 0.89 |
Previous close | 0.884 |
Average volume | 598.25k |
---|---|
YTD Change | +6.19% |
Beta | 0.2933 |
Diluted NAV (est) | 0.9829 |
Diluted NAV (last pub) | 0.9723 |
Premium/Discount | -10.07% |
Net Gearing | 0.00% |
Annual div (ADY) | 0.07 USD |
---|---|
Annual div yield (ADY) | 7.92% |
Div ex-date | Sep 26 2024 |
Div pay-date | Oct 29 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 14:34 GMT.
More ▼